<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Tutein Nolthenius, R.P.</title>
    <link>http://repub.eur.nl/res/aut/8051/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock (Article)</title>
      <link>http://repub.eur.nl/res/pub/8844/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>STUDY OBJECTIVES: We tested the effects of continuous infusion of
          N(G)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide
          (NO) synthesis, on cardiovascular performance and pulmonary gas exchange
          in patients with hyperdynamic septic shock. DESIGN: Prospective clinical
          study. SETTING: ICU of a university hospital. PATIENTS: Eleven critically
          ill patients with severe refractory septic shock. INTERVENTIONS: Standard
          hemodynamic measurements were made and blood samples taken before, during,
          and after 12 h of continuous infusion of 1 mg/kg/h of L-NAME. MEASUREMENTS
          AND RESULTS: Continuous infusion of L-NAME increased mean arterial
          pressure (MAP) from 65+/-3 (SEM) to 93+/-4 mm Hg and systemic vascular
          resistance (SVR) from 962+/-121 to 1,563+/-173 dyne x s x cm(-5)/m2.
          Parallel to this, cardiac index (CI) decreased from 4.8+/-0.4 to 3.9+/-0.4
          L/min/m2 and myocardial stroke volume (SV) was reduced from 43+/-3 to
          34+/-3 mL/m2. Left ventricular stroke work was increased in the first hour
          of L-NAME infusion from 31+/-3 to 43+/-4 g x m/m2 (all p&lt;0.01 compared
          with baseline). Heart rate, cardiac filling pressures, and right
          ventricular stroke work did not change significantly (p&gt;0.05). L-NAME
          increased the ratio of arterial PO2 to the fraction of inspired O2 from
          167+/-23 to 212+/-27 mm Hg (p&lt;0.05). Venous admixture (QVA/QT) was reduced
          from 19.4+/-2.6% to 14.2+/-2.1% (p&lt;0.05) and oxygen extraction ratio
          increased from 21.1+/-2.4% to 25.3+/-2.7% (p&lt;0.05). Oxygen delivery (DO2)
          was reduced following L-NAME, whereas oxygen uptake and arterial lactate
          and pH were unchanged. CONCLUSIONS: Prolonged inhibition of NO synthesis
          with L-NAME can restore MAP and SVR in patients with severe septic shock.
          Myocardial SV and CI decrease, probably as a result of increased
          afterload, since heart rate and stroke work were not reduced. L-NAME can
          improve pulmonary gas exchange with a concomitant reduction in QVA/QT.
          L-NAME did not promote anaerobe metabolism despite a reduction in DO2.</description>
    </item>
  </channel>
</rss>